Cargando…
Surveillance testing using salivary RT-PCR for SARS-CoV-2 in managed quarantine facilities in Australia: A laboratory validation and implementation study
BACKGROUND: Regular repeat surveillance testing is a strategy to identify asymptomatic individuals with SARS-CoV-2 infections in high-risk work settings to prevent onward community transmission. Saliva sampling is less invasive compared to nasal/oropharyngeal sampling, thus making it suitable for re...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263280/ https://www.ncbi.nlm.nih.gov/pubmed/35821908 http://dx.doi.org/10.1016/j.lanwpc.2022.100533 |
_version_ | 1784742698038591488 |
---|---|
author | Jenney, Adam Chibo, Doris Batty, Mitch Druce, Julian Melvin, Robert Stewardson, Andrew Dennison, Amanda Symes, Sally Kinsella, Paul Tran, Thomas Mackenzie, Charlene Johnson, Douglas Thevarajan, Irani McGrath, Christian Matlock, Amelia Prestedge, Jacqueline Gooey, Megan Roney, Janine Bobbitt, Joanne Yallop, Sarah Catton, Mike Williamson, Deborah A |
author_facet | Jenney, Adam Chibo, Doris Batty, Mitch Druce, Julian Melvin, Robert Stewardson, Andrew Dennison, Amanda Symes, Sally Kinsella, Paul Tran, Thomas Mackenzie, Charlene Johnson, Douglas Thevarajan, Irani McGrath, Christian Matlock, Amelia Prestedge, Jacqueline Gooey, Megan Roney, Janine Bobbitt, Joanne Yallop, Sarah Catton, Mike Williamson, Deborah A |
author_sort | Jenney, Adam |
collection | PubMed |
description | BACKGROUND: Regular repeat surveillance testing is a strategy to identify asymptomatic individuals with SARS-CoV-2 infections in high-risk work settings to prevent onward community transmission. Saliva sampling is less invasive compared to nasal/oropharyngeal sampling, thus making it suitable for regular testing. In this multi-centre evaluation, we aimed to validate RT-PCR using salivary swab testing of SARS-CoV-2 for large-scale surveillance testing and assess implementation amongst staff working in the hotel quarantine system in Victoria, Australia. METHODS: A multi-centre laboratory evaluation study was conducted to systematically validate the in vitro and clinical performance of salivary swab RT-PCR for implementation of SARS-CoV-2 surveillance testing. Analytical sensitivity for multiple RT-PCR platforms was assessed using a dilution series of known SARS-CoV-2 viral loads, and assay specificity was examined using a panel of viral pathogens other than SARS-CoV-2. In addition, we tested capacity for large-scale saliva testing using a four-sample pooling approach, where positive pools were subsequently decoupled and retested. Regular, frequent self-collected saliva swab RT-PCR testing was implemented for staff across fourteen quarantine hotels. Samples were tested at three diagnostic laboratories validated in this study, and results were provided back to staff in real-time. FINDINGS: The agreement of self-collected saliva swabs for RT-PCR was 84.5% (95% CI 68.6 to 93.8) compared to RT-PCR using nasal/oropharyngeal swab samples collected by a healthcare practitioner, when saliva samples were collected within seven days of symptom onset. Between 7th December 2020 and 17th December 2021, almost 500,000 RT-PCR tests were performed on saliva swabs self-collected by 102 staff working in quarantine hotels in Melbourne. Of these, 20 positive saliva swabs were produced by 13 staff (0.004%). The majority of staff that tested positive occurred during periods of community transmission of the SARS-CoV-2 Delta variant. INTERPRETATION: Salivary RT-PCR had an acceptable level of agreement compared to standard nasal/oropharyngeal swab RT-PCR within early symptom onset. The scalability, tolerability and ease of self-collection highlights utility for frequent or repeated testing in high-risk settings, such as quarantine or healthcare environments where regular monitoring of staff is critical for public health, and protection of vulnerable populations. FUNDING: This work was funded by the Victorian Department of Health. |
format | Online Article Text |
id | pubmed-9263280 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-92632802022-07-08 Surveillance testing using salivary RT-PCR for SARS-CoV-2 in managed quarantine facilities in Australia: A laboratory validation and implementation study Jenney, Adam Chibo, Doris Batty, Mitch Druce, Julian Melvin, Robert Stewardson, Andrew Dennison, Amanda Symes, Sally Kinsella, Paul Tran, Thomas Mackenzie, Charlene Johnson, Douglas Thevarajan, Irani McGrath, Christian Matlock, Amelia Prestedge, Jacqueline Gooey, Megan Roney, Janine Bobbitt, Joanne Yallop, Sarah Catton, Mike Williamson, Deborah A Lancet Reg Health West Pac Articles BACKGROUND: Regular repeat surveillance testing is a strategy to identify asymptomatic individuals with SARS-CoV-2 infections in high-risk work settings to prevent onward community transmission. Saliva sampling is less invasive compared to nasal/oropharyngeal sampling, thus making it suitable for regular testing. In this multi-centre evaluation, we aimed to validate RT-PCR using salivary swab testing of SARS-CoV-2 for large-scale surveillance testing and assess implementation amongst staff working in the hotel quarantine system in Victoria, Australia. METHODS: A multi-centre laboratory evaluation study was conducted to systematically validate the in vitro and clinical performance of salivary swab RT-PCR for implementation of SARS-CoV-2 surveillance testing. Analytical sensitivity for multiple RT-PCR platforms was assessed using a dilution series of known SARS-CoV-2 viral loads, and assay specificity was examined using a panel of viral pathogens other than SARS-CoV-2. In addition, we tested capacity for large-scale saliva testing using a four-sample pooling approach, where positive pools were subsequently decoupled and retested. Regular, frequent self-collected saliva swab RT-PCR testing was implemented for staff across fourteen quarantine hotels. Samples were tested at three diagnostic laboratories validated in this study, and results were provided back to staff in real-time. FINDINGS: The agreement of self-collected saliva swabs for RT-PCR was 84.5% (95% CI 68.6 to 93.8) compared to RT-PCR using nasal/oropharyngeal swab samples collected by a healthcare practitioner, when saliva samples were collected within seven days of symptom onset. Between 7th December 2020 and 17th December 2021, almost 500,000 RT-PCR tests were performed on saliva swabs self-collected by 102 staff working in quarantine hotels in Melbourne. Of these, 20 positive saliva swabs were produced by 13 staff (0.004%). The majority of staff that tested positive occurred during periods of community transmission of the SARS-CoV-2 Delta variant. INTERPRETATION: Salivary RT-PCR had an acceptable level of agreement compared to standard nasal/oropharyngeal swab RT-PCR within early symptom onset. The scalability, tolerability and ease of self-collection highlights utility for frequent or repeated testing in high-risk settings, such as quarantine or healthcare environments where regular monitoring of staff is critical for public health, and protection of vulnerable populations. FUNDING: This work was funded by the Victorian Department of Health. Elsevier 2022-07-08 /pmc/articles/PMC9263280/ /pubmed/35821908 http://dx.doi.org/10.1016/j.lanwpc.2022.100533 Text en © 2022 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Articles Jenney, Adam Chibo, Doris Batty, Mitch Druce, Julian Melvin, Robert Stewardson, Andrew Dennison, Amanda Symes, Sally Kinsella, Paul Tran, Thomas Mackenzie, Charlene Johnson, Douglas Thevarajan, Irani McGrath, Christian Matlock, Amelia Prestedge, Jacqueline Gooey, Megan Roney, Janine Bobbitt, Joanne Yallop, Sarah Catton, Mike Williamson, Deborah A Surveillance testing using salivary RT-PCR for SARS-CoV-2 in managed quarantine facilities in Australia: A laboratory validation and implementation study |
title | Surveillance testing using salivary RT-PCR for SARS-CoV-2 in managed quarantine facilities in Australia: A laboratory validation and implementation study |
title_full | Surveillance testing using salivary RT-PCR for SARS-CoV-2 in managed quarantine facilities in Australia: A laboratory validation and implementation study |
title_fullStr | Surveillance testing using salivary RT-PCR for SARS-CoV-2 in managed quarantine facilities in Australia: A laboratory validation and implementation study |
title_full_unstemmed | Surveillance testing using salivary RT-PCR for SARS-CoV-2 in managed quarantine facilities in Australia: A laboratory validation and implementation study |
title_short | Surveillance testing using salivary RT-PCR for SARS-CoV-2 in managed quarantine facilities in Australia: A laboratory validation and implementation study |
title_sort | surveillance testing using salivary rt-pcr for sars-cov-2 in managed quarantine facilities in australia: a laboratory validation and implementation study |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263280/ https://www.ncbi.nlm.nih.gov/pubmed/35821908 http://dx.doi.org/10.1016/j.lanwpc.2022.100533 |
work_keys_str_mv | AT jenneyadam surveillancetestingusingsalivaryrtpcrforsarscov2inmanagedquarantinefacilitiesinaustraliaalaboratoryvalidationandimplementationstudy AT chibodoris surveillancetestingusingsalivaryrtpcrforsarscov2inmanagedquarantinefacilitiesinaustraliaalaboratoryvalidationandimplementationstudy AT battymitch surveillancetestingusingsalivaryrtpcrforsarscov2inmanagedquarantinefacilitiesinaustraliaalaboratoryvalidationandimplementationstudy AT drucejulian surveillancetestingusingsalivaryrtpcrforsarscov2inmanagedquarantinefacilitiesinaustraliaalaboratoryvalidationandimplementationstudy AT melvinrobert surveillancetestingusingsalivaryrtpcrforsarscov2inmanagedquarantinefacilitiesinaustraliaalaboratoryvalidationandimplementationstudy AT stewardsonandrew surveillancetestingusingsalivaryrtpcrforsarscov2inmanagedquarantinefacilitiesinaustraliaalaboratoryvalidationandimplementationstudy AT dennisonamanda surveillancetestingusingsalivaryrtpcrforsarscov2inmanagedquarantinefacilitiesinaustraliaalaboratoryvalidationandimplementationstudy AT symessally surveillancetestingusingsalivaryrtpcrforsarscov2inmanagedquarantinefacilitiesinaustraliaalaboratoryvalidationandimplementationstudy AT kinsellapaul surveillancetestingusingsalivaryrtpcrforsarscov2inmanagedquarantinefacilitiesinaustraliaalaboratoryvalidationandimplementationstudy AT tranthomas surveillancetestingusingsalivaryrtpcrforsarscov2inmanagedquarantinefacilitiesinaustraliaalaboratoryvalidationandimplementationstudy AT mackenziecharlene surveillancetestingusingsalivaryrtpcrforsarscov2inmanagedquarantinefacilitiesinaustraliaalaboratoryvalidationandimplementationstudy AT johnsondouglas surveillancetestingusingsalivaryrtpcrforsarscov2inmanagedquarantinefacilitiesinaustraliaalaboratoryvalidationandimplementationstudy AT thevarajanirani surveillancetestingusingsalivaryrtpcrforsarscov2inmanagedquarantinefacilitiesinaustraliaalaboratoryvalidationandimplementationstudy AT mcgrathchristian surveillancetestingusingsalivaryrtpcrforsarscov2inmanagedquarantinefacilitiesinaustraliaalaboratoryvalidationandimplementationstudy AT matlockamelia surveillancetestingusingsalivaryrtpcrforsarscov2inmanagedquarantinefacilitiesinaustraliaalaboratoryvalidationandimplementationstudy AT prestedgejacqueline surveillancetestingusingsalivaryrtpcrforsarscov2inmanagedquarantinefacilitiesinaustraliaalaboratoryvalidationandimplementationstudy AT gooeymegan surveillancetestingusingsalivaryrtpcrforsarscov2inmanagedquarantinefacilitiesinaustraliaalaboratoryvalidationandimplementationstudy AT roneyjanine surveillancetestingusingsalivaryrtpcrforsarscov2inmanagedquarantinefacilitiesinaustraliaalaboratoryvalidationandimplementationstudy AT bobbittjoanne surveillancetestingusingsalivaryrtpcrforsarscov2inmanagedquarantinefacilitiesinaustraliaalaboratoryvalidationandimplementationstudy AT yallopsarah surveillancetestingusingsalivaryrtpcrforsarscov2inmanagedquarantinefacilitiesinaustraliaalaboratoryvalidationandimplementationstudy AT cattonmike surveillancetestingusingsalivaryrtpcrforsarscov2inmanagedquarantinefacilitiesinaustraliaalaboratoryvalidationandimplementationstudy AT williamsondeboraha surveillancetestingusingsalivaryrtpcrforsarscov2inmanagedquarantinefacilitiesinaustraliaalaboratoryvalidationandimplementationstudy |